Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study

Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institu...

Full description

Bibliographic Details
Main Authors: Chang Moo Kang, Kyung-Suk Suh, Nam-Joon Yi, Tae Ho Hong, Sang Jae Park, Keun Soo Ahn, Hiroki Hayashi, Sae Byeol Choi, Chi-Young Jeong, Takeshi Takahara, Shigehiro Shiozaki, Young Hoon Roh, Hee Chul Yu, Takumi Fukumoto, Ryusei Matsuyama, Uyama Naoki, Kazuki Hashida, Hyung Il Seo, Takehiro Okabayashi, Tomoo Kitajima, Sohei SATOI, Hiroaki Nagano, Hongbeom Kim, Kaoru Taira, Shoji Kubo, Dong Wook Choi
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/3/445
id doaj-51d0e0890cbd4f80b7922eed551250ea
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Chang Moo Kang
Kyung-Suk Suh
Nam-Joon Yi
Tae Ho Hong
Sang Jae Park
Keun Soo Ahn
Hiroki Hayashi
Sae Byeol Choi
Chi-Young Jeong
Takeshi Takahara
Shigehiro Shiozaki
Young Hoon Roh
Hee Chul Yu
Takumi Fukumoto
Ryusei Matsuyama
Uyama Naoki
Kazuki Hashida
Hyung Il Seo
Takehiro Okabayashi
Tomoo Kitajima
Sohei SATOI
Hiroaki Nagano
Hongbeom Kim
Kaoru Taira
Shoji Kubo
Dong Wook Choi
spellingShingle Chang Moo Kang
Kyung-Suk Suh
Nam-Joon Yi
Tae Ho Hong
Sang Jae Park
Keun Soo Ahn
Hiroki Hayashi
Sae Byeol Choi
Chi-Young Jeong
Takeshi Takahara
Shigehiro Shiozaki
Young Hoon Roh
Hee Chul Yu
Takumi Fukumoto
Ryusei Matsuyama
Uyama Naoki
Kazuki Hashida
Hyung Il Seo
Takehiro Okabayashi
Tomoo Kitajima
Sohei SATOI
Hiroaki Nagano
Hongbeom Kim
Kaoru Taira
Shoji Kubo
Dong Wook Choi
Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
Cancers
cholangiocarcinoma
lymph nodes
metastasis
nomograms
author_facet Chang Moo Kang
Kyung-Suk Suh
Nam-Joon Yi
Tae Ho Hong
Sang Jae Park
Keun Soo Ahn
Hiroki Hayashi
Sae Byeol Choi
Chi-Young Jeong
Takeshi Takahara
Shigehiro Shiozaki
Young Hoon Roh
Hee Chul Yu
Takumi Fukumoto
Ryusei Matsuyama
Uyama Naoki
Kazuki Hashida
Hyung Il Seo
Takehiro Okabayashi
Tomoo Kitajima
Sohei SATOI
Hiroaki Nagano
Hongbeom Kim
Kaoru Taira
Shoji Kubo
Dong Wook Choi
author_sort Chang Moo Kang
title Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_short Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_full Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_fullStr Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_full_unstemmed Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_sort should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? a collaborative korea–japan study
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-01-01
description Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), <i>p</i> < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), <i>p</i> < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), <i>p</i> = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed <i>p</i> = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC.
topic cholangiocarcinoma
lymph nodes
metastasis
nomograms
url https://www.mdpi.com/2072-6694/13/3/445
work_keys_str_mv AT changmookang shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kyungsuksuh shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT namjoonyi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT taehohong shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT sangjaepark shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT keunsooahn shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hirokihayashi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT saebyeolchoi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT chiyoungjeong shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT takeshitakahara shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT shigehiroshiozaki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT younghoonroh shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT heechulyu shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT takumifukumoto shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT ryuseimatsuyama shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT uyamanaoki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kazukihashida shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hyungilseo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT takehirookabayashi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT tomookitajima shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT soheisatoi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hiroakinagano shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hongbeomkim shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kaorutaira shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT shojikubo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT dongwookchoi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
_version_ 1724323683789438976
spelling doaj-51d0e0890cbd4f80b7922eed551250ea2021-01-26T00:03:00ZengMDPI AGCancers2072-66942021-01-011344544510.3390/cancers13030445Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan StudyChang Moo Kang0Kyung-Suk Suh1Nam-Joon Yi2Tae Ho Hong3Sang Jae Park4Keun Soo Ahn5Hiroki Hayashi6Sae Byeol Choi7Chi-Young Jeong8Takeshi Takahara9Shigehiro Shiozaki10Young Hoon Roh11Hee Chul Yu12Takumi Fukumoto13Ryusei Matsuyama14Uyama Naoki15Kazuki Hashida16Hyung Il Seo17Takehiro Okabayashi18Tomoo Kitajima19Sohei SATOI20Hiroaki Nagano21Hongbeom Kim22Kaoru Taira23Shoji Kubo24Dong Wook Choi25Department of Surgery, Yonsei University College of Medicine, Seoul 03722, KoreaDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Hepatobiliary and Pancreas Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaCenter for Liver Cancer, National Cancer Center, Goyang 10408, KoreaDepartment of Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu 42601, KoreaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai 980-8575, JapanDepartment of Surgery, Korea University College of Medicine, Seoul 02841, KoreaDepartment of Surgery, College of Medicine Gyeongsang National University, Jinju 52727, KoreaDepartment of Surgery, Iwate Medical University School of Medicine, Iwate 028-3694, JapanDepartment of Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima 730-8518, JapanDepartment of Surgery, Dong-A University College of Medicine, Busan 49201, KoreaDepartment of Surgery, Jeonbuk National University Medical School, Jeonju 54907, KoreaDepartment of Surgery, Kobe University Graduate School of Medicine, Kobe 657-850, JapanDepartment of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 326-0027, JapanDepartment of Surgery, Hyogo College of Medicine, Nishinomiya 663-8501, JapanDepartment of General Surgery, Kurashiki Central Hospital, Kurashiki 710-8602, JapanDepartment of Surgery, Pusan National University College of Medicine, Busan 49241, KoreaDepartment of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi 781-8555, JapanDepartment of Surgery, Nagasaki Medical Center, Nagasaki 856-0835, JapanDepartment of Surgery, Kansai Medical University, Osaka 573-1191, JapanDepartment of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, JapanDepartment of Surgery, Seoul National University College of Medicine, Seoul 03080, KoreaDepartment of Surgery, Otsu Red Cross Hospital, Otsu 520-0046, JapanDepartment of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Osaka City University, Osaka 558-0022, JapanDepartment of Surgery, Sungkyunkwan University School of Medicine, Seoul 16419, KoreaBackground: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), <i>p</i> < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), <i>p</i> < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), <i>p</i> = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed <i>p</i> = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC.https://www.mdpi.com/2072-6694/13/3/445cholangiocarcinomalymph nodesmetastasisnomograms